Design Therapeutics Overview

  • Status
  • Public
  • Employees
  • 33
Employees
  • Stock Symbol
  • DSGN
Stock Symbol
  • Share Price
  • $15.43
  • (As of Monday Closing)

Design Therapeutics General Information

Description

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Contact Information

Website
www.designtx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 6005 Hidden Valley Road
  • Suite 110
  • Carlsbad, CA 92011
  • United States
+1 (858) 000-0000

Design Therapeutics Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Design Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.43 $15.32 $10.37 - $50.50 $853M 55.7M 202K -$0.71

Design Therapeutics Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 406,799
Revenue 33 226 834
EBITDA (28,272) (8,275) (2,047)
Net Income (28,323) (8,280) (2,047)
Total Assets 400,353 36,516 90
Total Debt 3,748 0 695
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Design Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Design Therapeutics‘s full profile, request access.

Request a free trial

Design Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Design Therapeutics‘s full profile, request access.

Request a free trial

Design Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeu
Drug Discovery
Carlsbad, CA
33 As of 2021
00000
0.000 0000-00-00
00000000 00000

00000000

re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
0000000000000
South San Francisco, CA
00 As of 0000
00000
000000000 00000

0000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
0000000000000
Bala Cynwyd, PA
00 As of 0000
00000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Design Therapeutics Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cortexyme Formerly VC-backed South San Francisco, CA 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Bala Cynwyd, PA 00 00000 000000000
0000000 0000000000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed La Jolla, CA 000 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 25 competitors. Get the full list »

Design Therapeutics Patents

  • 10

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 6

    Pending

  • 000

    Expiring in next 12 mo

Design Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3818056-A1 Methods and compounds for the treatment of genetic disease Pending 03-Jul-2018 0000000000
EP-3797106-A1 Methods and compounds for the treatment of genetic disease Pending 22-May-2018 000000000
US-20210228723-A1 Methods and compounds for the treatment of genetic disease Pending 22-May-2018 0000000000
US-20210238226-A1 Methods and compounds for the treatment of genetic disease Pending 22-May-2018 00000000
EP-3797105-A1 Methods and compounds for the treatment of genetic disease Pending 22-May-2018 C07K7/02
To view Design Therapeutics’s complete patent history, request access »

Design Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Joao Siffert MD Chief Executive Officer & Chief Financial Officer, Finance
Sean Jeffries Ph.D Chief Operating Officer, Operations
Dawn Giangiulio Chief Accounting Officer, Accounting & Controller, Finance
Aseem Ansari Ph.D Co-Founder & Board Member
Jae Kim MD Chief Medical Officer
To view Design Therapeutics’s complete executive team members history, request access »

Design Therapeutics Board Members (9)

Name Representing Role Since
Arsani William MD Logos Capital Board Member 000 0000
Aseem Ansari Ph.D Design Therapeutics Co-Founder & Board Member 000 0000
Deepa Prasad WestRiver Group Board Member 000 0000
Heather Behanna Ph.D Self Board Member 000 0000
John Schmid Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Design Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Design Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Design Therapeutics‘s full profile, request access.

Request a free trial